Author(s): N.N. Gavrilova, I.A. Ratnikova, A.K. Sadanov, S.E. Orazymbet, E.Zh. Shorabaev, B.B. Baimakhanova, L.E. Protasiuk
DOI: 10.52711/0974-360X.2023.00682
Views:
5
(pdf),
879
(html)
Access:
Open Access
Cite: N.N. Gavrilova, I.A. Ratnikova, A.K. Sadanov, S.E. Orazymbet, E.Zh. Shorabaev, B.B. Baimakhanova, L.E. Protasiuk. Determination of the Toxicity and Sensitizing effect of a Therapeutic Probiotic agent against Intestinal and Concomitant human infections. Research Journal of Pharmacy and Technology 2023; 16(9):4161-1. doi: 10.52711/0974-360X.2023.00682
Read More
|
Author(s): A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
DOI: 10.52711/0974-360X.2024.00613
Views:
0
(pdf),
487
(html)
Access:
Closed Access
Cite: A.K. Sadanov, I.R. Kulmagambetov, F.N. Nurmanbetova, G. Zh. Sarsenbayeva, I.A. Ratnikova, S.Orazymbet, Ye.Zh. Shorabayev, B.B. Baimakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. First Phase of the Clinical trial of the AS-Probionorm Probiotic Medication for the treatment of Human Intestinal Infections. 2024; 17(8):39498-4. doi: 10.52711/0974-360X.2024.00613
Read More
|
Author(s): A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva
DOI: 10.52711/0974-360X.2024.00904
Views:
0
(pdf),
261
(html)
Access:
Closed Access
Cite: A.K. Sadanov, I.A. Ratnikova, S.E. Orasymbet, Ye.Zh. Shorabayev, B.B. Baymakhanova, L.Ye. Protasyuk, A.D. Massirbayeva. Developing Safe Probiotic Solutions for the Treatment of Human Intestinal Infections. Research Journal Pharmacy and Technology. 2024;17(12):5960-6. doi: 10.52711/0974-360X.2024.00904
Read More
|